ALGN vs. WST, COO, MMSI, ICUI, XRAY, HAE, QDEL, NEOG, STAA, and CERS
Should you be buying Align Technology stock or one of its competitors? The main competitors of Align Technology include West Pharmaceutical Services (WST), Cooper Companies (COO), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), QuidelOrtho (QDEL), Neogen (NEOG), STAAR Surgical (STAA), and Cerus (CERS). These companies are all part of the "health care supplies" industry.
Align Technology vs.
Align Technology (NASDAQ:ALGN) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, community ranking, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.
Align Technology currently has a consensus target price of $267.45, suggesting a potential upside of 18.18%. West Pharmaceutical Services has a consensus target price of $430.20, suggesting a potential upside of 25.41%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts clearly believe West Pharmaceutical Services is more favorable than Align Technology.
88.4% of Align Technology shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 0.6% of Align Technology shares are owned by insiders. Comparatively, 0.5% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Align Technology has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500. Comparatively, West Pharmaceutical Services has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.
West Pharmaceutical Services has a net margin of 17.37% compared to Align Technology's net margin of 11.15%. West Pharmaceutical Services' return on equity of 18.41% beat Align Technology's return on equity.
In the previous week, Align Technology had 3 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 15 mentions for Align Technology and 12 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 0.77 beat Align Technology's score of 0.52 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.
West Pharmaceutical Services has lower revenue, but higher earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.
Align Technology received 522 more outperform votes than West Pharmaceutical Services when rated by MarketBeat users. Likewise, 69.77% of users gave Align Technology an outperform vote while only 55.91% of users gave West Pharmaceutical Services an outperform vote.
Summary
West Pharmaceutical Services beats Align Technology on 11 of the 19 factors compared between the two stocks.
Get Align Technology News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALGN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Align Technology Competitors List
Related Companies and Tools
This page (NASDAQ:ALGN) was last updated on 1/30/2025 by MarketBeat.com Staff
